Cargando…

Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis

Lymphatic filariasis is a disease of considerable socioeconomic burden in the tropics. Presently used antifilarial drugs are able to strongly reduce transmission and will thus ultimately lower the burden of morbidity associated with the infection, however, a chemotherapeutic principle that directly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debrah, Alexander Yaw, Mand, Sabine, Specht, Sabine, Marfo-Debrekyei, Yeboah, Batsa, Linda, Pfarr, Kenneth, Larbi, John, Lawson, Bernard, Taylor, Mark, Adjei, Ohene, Hoerauf, Achim
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564427/ https://www.ncbi.nlm.nih.gov/pubmed/17044733 http://dx.doi.org/10.1371/journal.ppat.0020092

Ejemplares similares

Macrofilaricidal Activity in Wuchereria bancrofti after 2 Weeks Treatment with a Combination of Rifampicin plus Doxycycline
por: Debrah, Alexander Yaw, et al.
Publicado: (2011)

Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin
por: Debrah, Alexander Yaw, et al.
Publicado: (2006)

Doxycycline Improves Filarial Lymphedema Independent of Active Filarial Infection: A Randomized Controlled Trial
por: Mand, Sabine, et al.
Publicado: (2012)

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study
por: Hoerauf, Achim, et al.
Publicado: (2007)

Frequent detection of worm movements in onchocercal nodules by ultrasonography
por: Mand, Sabine, et al.
Publicado: (2005)

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study
por: Hoerauf, Achim, et al.
Publicado: (2008)

Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis
por: Mand, Sabine, et al.
Publicado: (2003)

Lymphatic Vascularisation and Involvement of Lyve-1(+) Macrophages in the Human Onchocerca Nodule
por: Attout, Tarik, et al.
Publicado: (2009)

Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial
por: Debrah, Alexander Yaw, et al.
Publicado: (2015)

Newly acquired Onchocerca volvulus filariae after doxycycline treatment
por: Specht, Sabine, et al.
Publicado: (2009)

Filariasis and lymphoedema
por: PFARR, K M, et al.
Publicado: (2009)

Elimination of lymphatic filariasis in South East Asia
por: Specht, Sabine, et al.
Publicado: (2019)

Review of Dancing Parasites in Lymphatic Filariasis
por: Dietrich, Christoph F., et al.
Publicado: (2019)

Morbidity management and surveillance of lymphatic filariasis disease and acute dermatolymphangioadenitis attacks using a mobile phone-based tool by community health volunteers in Ghana
por: Debrah, Linda Batsa, et al.
Publicado: (2020)

The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis
por: Horton, John, et al.
Publicado: (2020)

Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis
por: Johnston, Kelly L., et al.
Publicado: (2014)

Immunoepidemiological Profiling of Onchocerciasis Patients Reveals Associations with Microfilaria Loads and Ivermectin Intake on Both Individual and Community Levels
por: Arndts, Kathrin, et al.
Publicado: (2014)

Elevated Adaptive Immune Responses Are Associated with Latent Infections of Wuchereria bancrofti
por: Arndts, Kathrin, et al.
Publicado: (2012)

Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes
por: Prodjinotho, Ulrich F., et al.
Publicado: (2017)

Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial
por: Klarmann-Schulz, Ute, et al.
Publicado: (2017)

Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana
por: Adu Mensah, Derrick, et al.
Publicado: (2022)

PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GIST
por: Hansson, E K, et al.
Publicado: (2013)

Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients
por: Zarychta, Elżbieta, et al.
Publicado: (2023)

The Efficacy of Doxycycline Treatment on Mansonella perstans Infection: An Open-Label, Randomized Trial in Ghana
por: Batsa Debrah, Linda, et al.
Publicado: (2019)

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
por: Kujala, Anni, et al.
Publicado: (2022)

Developing a community-led SMS reporting tool for the rapid assessment of lymphatic filariasis morbidity burden: case studies from Malawi and Ghana
por: Stanton, Michelle C., et al.
Publicado: (2015)

Gene polymorphisms and serum levels of sVEGFR-1 in patients with systemic lupus erythematosus
por: Yuan, Zhi-Chao, et al.
Publicado: (2020)

sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Spearman, Andrew D., et al.
Publicado: (2021)

Therapeutic Efficacy and Macrofilaricidal Activity of Doxycycline for the Treatment of River Blindness
por: Walker, Martin, et al.
Publicado: (2015)

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use
por: Wu, Florence T H, et al.
Publicado: (2010)

Commentary: sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Putotto, Carolina, et al.
Publicado: (2021)

Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
por: Şalk, Sultan, et al.
Publicado: (2022)

Macrofilaricidal Activity after Doxycycline Only Treatment of Onchocerca volvulus in an Area of Loa loa Co-Endemicity: A Randomized Controlled Trial
por: Turner, Joseph D., et al.
Publicado: (2010)

Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy
por: Jürgensmeier, J M, et al.
Publicado: (2013)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Reductions in microfilaridermia by repeated ivermectin treatment are associated with lower Plasmodium-specific Th17 immune responses in Onchocerca volvulus-infected individuals
por: Arndts, Kathrin, et al.
Publicado: (2015)

Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
por: TAYLOR, MARK J., et al.
Publicado: (2014)

Single nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti
por: Debrah, Linda Batsa, et al.
Publicado: (2017)

Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators
por: Biritwum, Nana-Kwadwo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8hoa1rpd16b2rvt64u7hcvhqnr